Characterization of quantitative and functional innate immune parameters in HIV-1-infected Colombian children receiving stable highly active antiretroviral therapy

ABSTRACT:Background: The immunological benefits of highly active antiretroviral therapy (HAART) in HIV-1-infected children include reconstitution of CD4+ T-cell count and functional activity. The effect of HAART on innate immune cells has not been well established.Aim: To characterize innate immune...

Full description

Autores:
Usuga Perilla, Xiomara
Montoya Guarín, Carlos Julio
Landay, Alan L.
Rugeles López, María Teresa
Tipo de recurso:
Article of investigation
Fecha de publicación:
2008
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/36730
Acceso en línea:
https://hdl.handle.net/10495/36730
Palabra clave:
Adolescente
Adolescent
Fármacos Anti-VIH
Anti-HIV Agents
Terapia Antirretroviral Altamente Activa
Antiretroviral Therapy, Highly Active
Antígeno B7-1
B7-1 Antigen
Citocinas
Cytokines
Células Dendríticas
Dendritic Cells
Inmunidad Innata
Immunity, Innate
Interferón-alfa
Interferon-alpha
Células T Asesinas Naturales
Natural Killer T-Cells
Rights
openAccess
License
https://creativecommons.org/licenses/by-nc-nd/4.0/
id UDEA2_c5414907b1c1f2afb558d30bba7d6ba4
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/36730
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Characterization of quantitative and functional innate immune parameters in HIV-1-infected Colombian children receiving stable highly active antiretroviral therapy
title Characterization of quantitative and functional innate immune parameters in HIV-1-infected Colombian children receiving stable highly active antiretroviral therapy
spellingShingle Characterization of quantitative and functional innate immune parameters in HIV-1-infected Colombian children receiving stable highly active antiretroviral therapy
Adolescente
Adolescent
Fármacos Anti-VIH
Anti-HIV Agents
Terapia Antirretroviral Altamente Activa
Antiretroviral Therapy, Highly Active
Antígeno B7-1
B7-1 Antigen
Citocinas
Cytokines
Células Dendríticas
Dendritic Cells
Inmunidad Innata
Immunity, Innate
Interferón-alfa
Interferon-alpha
Células T Asesinas Naturales
Natural Killer T-Cells
title_short Characterization of quantitative and functional innate immune parameters in HIV-1-infected Colombian children receiving stable highly active antiretroviral therapy
title_full Characterization of quantitative and functional innate immune parameters in HIV-1-infected Colombian children receiving stable highly active antiretroviral therapy
title_fullStr Characterization of quantitative and functional innate immune parameters in HIV-1-infected Colombian children receiving stable highly active antiretroviral therapy
title_full_unstemmed Characterization of quantitative and functional innate immune parameters in HIV-1-infected Colombian children receiving stable highly active antiretroviral therapy
title_sort Characterization of quantitative and functional innate immune parameters in HIV-1-infected Colombian children receiving stable highly active antiretroviral therapy
dc.creator.fl_str_mv Usuga Perilla, Xiomara
Montoya Guarín, Carlos Julio
Landay, Alan L.
Rugeles López, María Teresa
dc.contributor.author.none.fl_str_mv Usuga Perilla, Xiomara
Montoya Guarín, Carlos Julio
Landay, Alan L.
Rugeles López, María Teresa
dc.contributor.researchgroup.spa.fl_str_mv Inmunovirología
dc.subject.decs.none.fl_str_mv Adolescente
Adolescent
Fármacos Anti-VIH
Anti-HIV Agents
Terapia Antirretroviral Altamente Activa
Antiretroviral Therapy, Highly Active
Antígeno B7-1
B7-1 Antigen
Citocinas
Cytokines
Células Dendríticas
Dendritic Cells
Inmunidad Innata
Immunity, Innate
Interferón-alfa
Interferon-alpha
Células T Asesinas Naturales
Natural Killer T-Cells
topic Adolescente
Adolescent
Fármacos Anti-VIH
Anti-HIV Agents
Terapia Antirretroviral Altamente Activa
Antiretroviral Therapy, Highly Active
Antígeno B7-1
B7-1 Antigen
Citocinas
Cytokines
Células Dendríticas
Dendritic Cells
Inmunidad Innata
Immunity, Innate
Interferón-alfa
Interferon-alpha
Células T Asesinas Naturales
Natural Killer T-Cells
description ABSTRACT:Background: The immunological benefits of highly active antiretroviral therapy (HAART) in HIV-1-infected children include reconstitution of CD4+ T-cell count and functional activity. The effect of HAART on innate immune cells has not been well established.Aim: To characterize innate immune responses in HAART-treated HIV-1-infected children. Patients and methods: 23 HIV-1-infected children on stable HAART and 23 uninfected children were evaluated. The frequency of innate immune cells in peripheral blood was determined by flow cytometry and functional activity was evaluated using Toll-like receptor agonists. Results: Compared with uninfected children, HAART-treated HIV-1-infected children exhibited a significant decrease in the frequency of plasmacytoid dendritic cells and natural killer and T-cell receptor (TCR)-invariant CD1d-restricted T cells. This deficiency of innate immune cells was observed mainly in children with detectable viral load. We also compared the magnitude of the quantitative restoration of those cells comparing HIV-1-infected children with HIV-1-infected adults and found a partial effect of HAART on immune restoration that was independent of age. In both pediatric and adult subjects Toll-like receptor agonists induced expression of costimulatory molecules and production of proinflammatory cytokines by dendritic cells. Peripheral blood mononuclear cells of HIV-1-infected children produced significantly reduced amounts of interferon-alpha compared with uninfected children.Conclusions: HAART administration to HIV-1-infected children does not lead to a complete increase of circulating innate immune cells, particularly in patients with incomplete suppression of HIV.
publishDate 2008
dc.date.issued.none.fl_str_mv 2008
dc.date.accessioned.none.fl_str_mv 2023-10-02T15:22:20Z
dc.date.available.none.fl_str_mv 2023-10-02T15:22:20Z
dc.type.spa.fl_str_mv Artículo de investigación
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.citation.spa.fl_str_mv Usuga X, Montoya CJ, Landay AL, Rugeles MT. Characterization of quantitative and functional innate immune parameters in HIV-1-infected Colombian children receiving stable highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):348-57. doi: 10.1097/qai.0b013e31818c16ff. PMID: 19186348.
dc.identifier.issn.none.fl_str_mv 1525-4135
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/10495/36730
dc.identifier.doi.none.fl_str_mv 10.1097/QAI.0b013e31818c16ff
dc.identifier.eissn.none.fl_str_mv 1944-7884
identifier_str_mv Usuga X, Montoya CJ, Landay AL, Rugeles MT. Characterization of quantitative and functional innate immune parameters in HIV-1-infected Colombian children receiving stable highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):348-57. doi: 10.1097/qai.0b013e31818c16ff. PMID: 19186348.
1525-4135
10.1097/QAI.0b013e31818c16ff
1944-7884
url https://hdl.handle.net/10495/36730
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv J. Acquir. Immune Defic. Syndr.
dc.relation.citationendpage.spa.fl_str_mv 357
dc.relation.citationissue.spa.fl_str_mv 4
dc.relation.citationstartpage.spa.fl_str_mv 348
dc.relation.citationvolume.spa.fl_str_mv 49
dc.relation.ispartofjournal.spa.fl_str_mv Journal of Acquired Immune Deficiency Syndromes
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.spa.fl_str_mv 10
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Williams & Wilkins
dc.publisher.place.spa.fl_str_mv Hagerstown, Estados Unidos
institution Universidad de Antioquia
bitstream.url.fl_str_mv https://bibliotecadigital.udea.edu.co/bitstreams/aabc05bb-8a2a-4e4a-a3d6-02c4925bd9f1/download
https://bibliotecadigital.udea.edu.co/bitstreams/36fb77e0-ddf5-49a6-8f12-385bf09ac73a/download
https://bibliotecadigital.udea.edu.co/bitstreams/11a84710-df46-485b-9821-65cd96862075/download
https://bibliotecadigital.udea.edu.co/bitstreams/7709f152-4ed7-4008-884e-577f4e36b948/download
bitstream.checksum.fl_str_mv 6da00c1fac4fb6489b14ee25278b5ae6
8a4605be74aa9ea9d79846c1fba20a33
d0c51760908f6c5f4a558af42e650104
c502e224a86a8a96b977b0a08ff68e4e
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional de la Universidad de Antioquia
repository.mail.fl_str_mv aplicacionbibliotecadigitalbiblioteca@udea.edu.co
_version_ 1851052446461198336
spelling Usuga Perilla, XiomaraMontoya Guarín, Carlos JulioLanday, Alan L.Rugeles López, María TeresaInmunovirología2023-10-02T15:22:20Z2023-10-02T15:22:20Z2008Usuga X, Montoya CJ, Landay AL, Rugeles MT. Characterization of quantitative and functional innate immune parameters in HIV-1-infected Colombian children receiving stable highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):348-57. doi: 10.1097/qai.0b013e31818c16ff. PMID: 19186348.1525-4135https://hdl.handle.net/10495/3673010.1097/QAI.0b013e31818c16ff1944-7884ABSTRACT:Background: The immunological benefits of highly active antiretroviral therapy (HAART) in HIV-1-infected children include reconstitution of CD4+ T-cell count and functional activity. The effect of HAART on innate immune cells has not been well established.Aim: To characterize innate immune responses in HAART-treated HIV-1-infected children. Patients and methods: 23 HIV-1-infected children on stable HAART and 23 uninfected children were evaluated. The frequency of innate immune cells in peripheral blood was determined by flow cytometry and functional activity was evaluated using Toll-like receptor agonists. Results: Compared with uninfected children, HAART-treated HIV-1-infected children exhibited a significant decrease in the frequency of plasmacytoid dendritic cells and natural killer and T-cell receptor (TCR)-invariant CD1d-restricted T cells. This deficiency of innate immune cells was observed mainly in children with detectable viral load. We also compared the magnitude of the quantitative restoration of those cells comparing HIV-1-infected children with HIV-1-infected adults and found a partial effect of HAART on immune restoration that was independent of age. In both pediatric and adult subjects Toll-like receptor agonists induced expression of costimulatory molecules and production of proinflammatory cytokines by dendritic cells. Peripheral blood mononuclear cells of HIV-1-infected children produced significantly reduced amounts of interferon-alpha compared with uninfected children.Conclusions: HAART administration to HIV-1-infected children does not lead to a complete increase of circulating innate immune cells, particularly in patients with incomplete suppression of HIV.COL001244410application/pdfengWilliams & WilkinsHagerstown, Estados Unidoshttps://creativecommons.org/licenses/by-nc-nd/4.0/http://creativecommons.org/licenses/by-nc-nd/2.5/co/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Characterization of quantitative and functional innate immune parameters in HIV-1-infected Colombian children receiving stable highly active antiretroviral therapyArtículo de investigaciónhttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionAdolescenteAdolescentFármacos Anti-VIHAnti-HIV AgentsTerapia Antirretroviral Altamente ActivaAntiretroviral Therapy, Highly ActiveAntígeno B7-1B7-1 AntigenCitocinasCytokinesCélulas DendríticasDendritic CellsInmunidad InnataImmunity, InnateInterferón-alfaInterferon-alphaCélulas T Asesinas NaturalesNatural Killer T-CellsJ. Acquir. Immune Defic. Syndr.357434849Journal of Acquired Immune Deficiency SyndromesPublicationORIGINALUsugaXiomara_2008_CharacterizationQuantitativeFunctional.pdfUsugaXiomara_2008_CharacterizationQuantitativeFunctional.pdfArtículo de investigaciónapplication/pdf589141https://bibliotecadigital.udea.edu.co/bitstreams/aabc05bb-8a2a-4e4a-a3d6-02c4925bd9f1/download6da00c1fac4fb6489b14ee25278b5ae6MD51trueAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/36fb77e0-ddf5-49a6-8f12-385bf09ac73a/download8a4605be74aa9ea9d79846c1fba20a33MD52falseAnonymousREADTEXTUsugaXiomara_2008_CharacterizationQuantitativeFunctional.pdf.txtUsugaXiomara_2008_CharacterizationQuantitativeFunctional.pdf.txtExtracted texttext/plain56789https://bibliotecadigital.udea.edu.co/bitstreams/11a84710-df46-485b-9821-65cd96862075/downloadd0c51760908f6c5f4a558af42e650104MD53falseAnonymousREADTHUMBNAILUsugaXiomara_2008_CharacterizationQuantitativeFunctional.pdf.jpgUsugaXiomara_2008_CharacterizationQuantitativeFunctional.pdf.jpgGenerated Thumbnailimage/jpeg17671https://bibliotecadigital.udea.edu.co/bitstreams/7709f152-4ed7-4008-884e-577f4e36b948/downloadc502e224a86a8a96b977b0a08ff68e4eMD54falseAnonymousREAD10495/36730oai:bibliotecadigital.udea.edu.co:10495/367302025-03-26 22:29:18.024https://creativecommons.org/licenses/by-nc-nd/4.0/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.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